Filing Flows

Filing Flows › Comparisons › AXGN vs CBLL

Axogen vs Ceribell: AXGN and CBLL compared

Axogen is the larger company: $75.8M of revenue in its latest quarter (Q3 2026) against $29.3M for Ceribell (Q3 2026). Ceribell is growing faster (+30% against +26% a year earlier). Axogen is more profitable, with an operating margin of 1.3% against -70.0%.

Axogen vs Ceribell, latest quarterAxogen vs Ceribell, latest quarterAxogen (AXGN)Ceribell (CBLL)Revenue$75.8M$29.3MRevenue growth, Y/Y+26%+30%Operating margin1.3%-70.0%Net margin3.1%-72.8%

Where the money goes: AXGN and CBLL

Axogen (AXGN) · Q3 2026

Axogen, Q3 2026: revenue $75.8M (+26% year over year), operating margin 1.3%, net earnings $2.3M, operating cash flow $16.5M. The chart follows the revenue to costs, profit and cash.

Ceribell (CBLL) · Q3 2026

Ceribell, Q3 2026: revenue $29.3M (+30% year over year), operating margin -70.0%, net loss $21.4M, operating cash flow −$13.1M. The chart follows the revenue to costs, profit and cash.

Ceribell revenue by segment, Q3 2026Ceribell revenue by segment, Q3 2026Product$22.2MSubscription$7.1M
Axogen (AXGN)Ceribell (CBLL)
Latest quarterQ3 2026Q3 2026
Revenue$75.8M$29.3M
Revenue growth, Y/Y+26%+30%
Gross margin74.8%—
Operating margin1.3%-70.0%
Net earnings$2.3M−$21.4M
Net margin3.1%-72.8%
Operating cash flow$16.5M−$13.1M
Free cash flow$15.1M—

Where the revenue comes from

Ceribell

Questions

Which is bigger, Axogen or Ceribell?

Axogen is the larger company: $75.8M of revenue in its latest quarter (Q3 2026) against $29.3M for Ceribell (Q3 2026).

Is Axogen or Ceribell growing faster?

Ceribell is growing faster (+30% against +26% a year earlier).

Which is more profitable, Axogen or Ceribell?

Axogen is more profitable, with an operating margin of 1.3% against -70.0%.

More: Axogen earnings · how Axogen makes money · Ceribell earnings · how Ceribell makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.